Intended for healthcare professionals

Papers Drug points

Gabapentin induced cholestasis

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.635 (Published 21 September 2002) Cite this as: BMJ 2002;325:635

This article has a correction. Please see:

  1. Charles E Richardson,
  2. Dylan W Williams,
  3. Jeremy G C Kingham (jkingham@swansea-tr.wales.nhs.uk)
  1. Department of Gastroenterology
  2. Department of Pathology, Singleton Hospital, Swansea SA2 8QA
  1. Correspondence to: JGC Kingham

    The treatment of painful diabetic peripheral neuropathy is troublesome and limited by the range of effective treatments available. Optimal control of diabetes is important, and simple analgesics such as aspirin and paracetamol may be beneficial. Further relief of symptoms may be achieved with tricyclic antidepressants and anticonvulsants.1 2 Unfortunately, despite these treatments many patients still have symptoms and the search for more effective therapy continues. Preliminary studies have shown that the anticonvulsant gabapentin is beneficial in the management of this condition, but this remains an unlicensed indication. We report a case of serious hepatotoxicity associated with gabapentin. 3 4

    During a routine visit to a …

    View Full Text